Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
LENZ Therapeutics, Inc. (LENZ) had Return on Equity of -7.61% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-14.62M |
|
-- |
|
-- |
|
$16.93M |
|
$-16.93M |
|
$2.31M |
|
$-14.62M |
|
$-14.62M |
|
$-14.62M |
|
$-14.62M |
|
$-14.62M |
|
$-14.62M |
|
$-16.93M |
|
$-18.03M |
|
27.53M |
|
27.53M |
|
$-0.53 |
|
$-0.53 |
|
| Balance Sheet Financials | |
$197.86M |
|
$0.93M |
|
$3.39M |
|
$201.25M |
|
$8.57M |
|
-- |
|
$0.67M |
|
$9.24M |
|
$192.01M |
|
$192.01M |
|
$192.01M |
|
27.54M |
|
| Cash Flow Statement Financials | |
$-16.05M |
|
$18.89M |
|
$0.04M |
|
$20.27M |
|
$23.16M |
|
$2.88M |
|
$2.56M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
23.09 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-16.16M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-7.61% |
-7.61% |
|
-7.26% |
|
-7.61% |
|
$6.97 |
|
$-0.59 |
|
$-0.58 |
|